Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bagley, R. G.
Right arrow Articles by Teicher, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bagley, R. G.
Right arrow Articles by Teicher, B. A.
[Cancer Research 65, 9741-9750, November 1, 2005]
© 2005 American Association for Cancer Research


Cell and Tumor Biology

Pericytes and Endothelial Precursor Cells: Cellular Interactions and Contributions to Malignancy

Rebecca G. Bagley, William Weber, Cecile Rouleau and Beverly A. Teicher

Genzyme Corp., Framingham, Massachusetts

Requests for reprints: Rebecca G. Bagley, Genzyme Corp., 5 Mountain Road, Framingham, MA 01701-9322. Phone: 508-270-2455; Fax: 508-872-9080; E-mail: Rebecca.Bagley{at}genzyme.com.

Tumor vasculature is irregular, abnormal, and essential for tumor growth. Pericytes and endothelial precursor cells (EPC) contribute to the formation of blood vessels under angiogenic conditions. As primary cells in culture, pericytes and EPC share many properties such as tube/network formation and response to kinase inhibitors selective for angiogenic pathways. Expression of cell surface proteins including platelet-derived growth factor receptor, vascular cell adhesion molecule, intercellular adhesion molecule, CD105, desmin, and neural growth proteoglycan 2 was similar between pericytes and EPC, whereas expression of P1H12 and lymphocyte function–associated antigen-1 clearly differentiates the cell types. Further distinction was observed in the molecular profiles for expression of angiogenic genes. Pericytes or EPC enhanced the invasion of MDA-MB-231 breast cancer cells in a coculture assay system. The s.c. coinjection of live pericytes or EPC along with MDA-MB-231 cells resulted in an increased rate of tumor growth compared with coinjection of irradiated pericytes or EPC. Microvessel density analysis indicated there was no difference in MDA-MB-231 tumors with or without EPC or pericytes. However, immunohistochemical staining of vasculature suggested that EPC and pericytes may stabilize or normalize vasculature rather than initiate vasculogenesis. In addition, tumors arising from the coinjection of EPC and cancer cells were more likely to develop lymphatic vessels. These results support the notion that pericytes and EPC contribute to malignancy and that these cell types can be useful as cell-based models for tumor vascular development and selection of agents that may provide therapeutic benefit.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
R. G. Bagley, C. Rouleau, T. St. Martin, P. Boutin, W. Weber, M. Ruzek, N. Honma, M. Nacht, S. Shankara, S. Kataoka, et al.
Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248
Mol. Cancer Ther., August 1, 2008; 7(8): 2536 - 2546.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
I. Thomassin-Naggara, M. Bazot, E. Darai, P. Callard, J. Thomassin, and C. A. Cuenod
Epithelial Ovarian Tumors: Value of Dynamic Contrast-enhanced MR Imaging and Correlation with Tumor Angiogenesis
Radiology, July 1, 2008; 248(1): 148 - 159.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Bhati, C. Patterson, C. A. Livasy, C. Fan, D. Ketelsen, Z. Hu, E. Reynolds, C. Tanner, D. T. Moore, F. Gabrielli, et al.
Molecular Characterization of Human Breast Tumor Vascular Cells
Am. J. Pathol., May 1, 2008; 172(5): 1381 - 1390.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Christian, R. Winkler, I. Helfrich, A. M. Boos, E. Besemfelder, D. Schadendorf, and H. G. Augustin
Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel-Associated Mural Cells
Am. J. Pathol., February 1, 2008; 172(2): 486 - 494.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Granot, Y. Addadi, V. Kalchenko, A. Harmelin, L. A. Kunz-Schughart, and M. Neeman
In vivo Imaging of the Systemic Recruitment of Fibroblasts to the Angiogenic Rim of Ovarian Carcinoma Tumors
Cancer Res., October 1, 2007; 67(19): 9180 - 9189.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
N. L. Boyd, S. K. Dhara, R. Rekaya, E. A. Godbey, K. Hasneen, R. R. Rao, F. D. West III, B. A. Gerwe, and S. L. Stice
BMP4 Promotes Formation of Primitive Vascular Networks in Human Embryonic Stem Cell-Derived Embryoid Bodies
Experimental Biology and Medicine, June 1, 2007; 232(6): 833 - 843.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. D. Roberts, J. S. Isenberg, L. A. Ridnour, and D. A. Wink
Nitric Oxide and Its Gatekeeper Thrombospondin-1 in Tumor Angiogenesis
Clin. Cancer Res., February 1, 2007; 13(3): 795 - 798.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.